IP Library Granted Patent US 12,466,846
Granted Patent B2
US 12,466,846 · App. 18/112,790 · Granted Nov 11, 2025

Siloxane derivatives of amino acids having surface-active properties

Inventors: Edward Asirvatham (Chatham, NJ); Kavssery Parameswaran Ananthapadmanabhan (Loveland, OH); Harshita Kumari (Cincinnati, OH); Ramana Reddy Mittapalli (Cincinnati, OH); Marzieh Susanna Mirzamani (Cincinnati, OH)
Assignee: AdvanSix Resins & Chemicals LLC
C07F7/0838C07F7/081
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,466,846
App. No.
18/112,790
Granted
Nov 11, 2025
Kind
B2
Abstract

The present disclosure provides siloxane derivatives of amino acids that have surface-active properties. The amino acid can be naturally-occurring or synthetic, or they may be obtained via a ring-opening reaction of a lactam, such as caprolactam. The amino acid may be functionalized with a siloxane group to form a compound that is surface-active and has surfactant characteristics. The compounds have low critical micelle concentrations (CMC) as well as the ability to lower the surface tension of a liquid.

Claims (31)

1 . A compound of Formula I:

wherein R 1 and R 2 are the same or different, and comprise at least one group selected from the group consisting of C 1 -C 6 alkyl, optionally the C 1 -C 6 alkyl may include one or more of oxygen, nitrogen, or sulfur atoms or groups that include at least one of these atoms, and the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;

R 3 is selected from the group consisting of alkenyl, alkynyl, ester, alcohol, aryl alkyl, alkoxy alkyl ether, alkyl phosphate, C 3 -C 8 carboxylic acid, C 1 -C 10 alkyl benzoic acid, and a C 1 -C 6 linker attached to a second molecule of Formula I, wherein the second molecule is the same or different;

n is an integer from 1 to 12; and

X is selected from the group consisting of chloride, bromide, and iodide.

2 . The compound of claim 1 , wherein R 3 is selected from the group consisting of C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 2 -C 12 ester, C 1 -C 10 hydroxyl, benzyl, C 2 -C 12 alkoxy alkyl ether, alkyl phosphate, C 3 -C 8 carboxylic acid, C 1 -C 10 alkyl benzoic acid, and a three-carbon linker attached to a second molecule of Formula I, wherein the second molecule is the same as the first molecule.

3 . The compound of claim 1 , wherein R 3 is selected from the formulas consisting of:

4 . The compound of claim 1 , wherein R 1 and R 2 are methyl.

5 . The compound of claim 1 , wherein n is 5.

6 . The compound of claim 1 , wherein the compound is N-benzyl-6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N-dimethyl-6-oxohexan-1-aminium bromide, having the following formula:

7 . The compound of claim 1 , wherein the compound is N-(2-ethoxy-2-oxoethyl)-6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N-dimethyl-6-oxohexan-1-aminium bromide, having the following formula:

8 . The compound of claim 1 , wherein the compound is N-allyl-6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N-dimethyl-6-oxohexan-1-aminium iodide, having the following formula:

9 . The compound of claim 1 , wherein the compound is 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N-dimethyl-6-oxo-N-(prop-2-yn-1-yl)hexan-1-aminium bromide, having the following formula:

10 . The compound of claim 1 , wherein the compound is 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N-(2-(2-methoxyethoxy)ethyl)-N,N-dimethyl-6-oxohexan-1-aminium bromide, having the following formula:

11 . The compound of claim 1 , wherein the compound is N-(3-(diethoxyphosphoryl)propyl)-6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N-dimethyl-6-oxohexan-1-aminium bromide, having the following formula:

12 . The compound of claim 1 , wherein the compound is 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N-(3-hydroxypropyl)-N,N-dimethyl-6-oxohexan-1-aminium iodide, having the following formula:

13 . The compound of claim 1 , wherein the compound is 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N-(2-hydroxyethyl)-N,N-dimethyl-6-oxohexan-1-aminium iodide, having the following formula:

14 . The compound of claim 1 , wherein the compound is N-(5-carboxypentyl)-6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N-dimethyl-6-oxohexan-1-aminium bromide, having the following formula:

15 . The compound of claim 1 , wherein the compound is N 1 ,N 3 -bis(6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-6-oxohexyl)-N 1 ,N 1 ,N 3 ,N 3 -tetramethylpropane-1,3-diaminium dibromide, having the formula:

16 . A method of synthesizing a compound of Formula I

wherein R 1 and R 2 are the same or different, and comprise at least one group selected from the group consisting of C 1 -C 6 alkyl, optionally the C 1 -C 6 alkyl may include one or more of oxygen, nitrogen, or sulfur atoms or groups that include at least one of these atoms, and the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;

R 3 is selected from the group consisting of alkenyl, alkynyl, ester, alcohol, aryl alkyl, alkoxy alkyl ether, alkyl phosphate, C 3 -C 8 carboxylic acid, C 1 -C 10 alkyl benzoic acid, and a C 1 -C 6 linker attached to a second molecule of Formula I, wherein the second molecule is the same or different;

n is an integer from 1 to 12; and

X is selected from the group consisting of chloride, bromide, and iodide, the method comprising:

a ring opening step to open lactam ring to provide an amino acid having an N-terminus and a C-terminus;

a first alkylation step, to alkylate the N-terminus to provide a tertiary amine;

a coupling step, to react the C-terminus with 3-aminopropyltris(trimethylsiloxy)silane to provide siloxane derivative; and

a second alkylation step, to alkylate the N-terminus to provide a quaternary amine of Formula I.

17 . The method of claim 16 , wherein the lactam is caprolactam.

18 . The method of claim 16 , wherein in the first alkylation step, the tertiary amine is 6-(dimethylamino)hexanoic acid.

19 . The method of claim 16 , wherein in the second alkylation step, the N-terminus is alkylated with an alkylating agent selected from the group consisting of benzyl bromide, ethyl bromoacetate, allyl iodide, propargyl bromide, 1-bromo-2-(2-methoxyethoxy)ethane, bromo phosphonate, 3-iodopropanol, 3-bromopropanol, 2-iodoethanol, 2-bromoethanol, 6-bromohexanoic acid, and 1,3-dibromopropane.

Continuity (2)
Provisional Application 63313115 · Feb 23, 2022
Related Publication 20230265112A1 · Aug 24, 2023
References Cited (87)
US 3624120A · Yetter · 1971 [cited by applicant]
US 3929678A · Laughlin et al. · 1975 [cited by applicant]
US 5041590A · Snow · 1991 [cited by applicant]
US 5162155A · Berndt et al. · 1992 [cited by applicant]
US 6013683A · Hill et al. · 2000 [cited by applicant]
US 7622512B2 · Schorzman et al. · 2009 [cited by applicant]
US 10053619B2 · Saboowala et al. · 2018 [cited by applicant]
US 11008348B2 · Asirvatham et al. · 2021 [cited by applicant]
US 11427760B2 · Asirvatham · 2022 [cited by applicant]
US 11525105B2 · Asirvatham · 2022 [cited by applicant]
US 11542428B2 · Asirvatham · 2023 [cited by applicant]
US 11571377B2 · Asirvatham · 2023 [cited by applicant]
US 11633481B2 · Asirvatham · 2023 [cited by applicant]
US 11891568B2 · Asirvatham · 2024 [cited by applicant]
US 11905304B2 · Asirvatham · 2024 [cited by applicant]
US 11952394B2 · Asirvatham et al. · 2024 [cited by applicant]
US 11999890B2 · Asirvatham · 2024 [cited by applicant]
US 12049589B2 · Asirvatham · 2024 [cited by applicant]
US 12054663B2 · Asirvatham · 2024 [cited by applicant]
US 20070099805A1 · Phenis et al. · 2007 [cited by applicant]
US 20070104778A1 · Zeng et al. · 2007 [cited by applicant]
US 20070142583A1 · Schorzman et al. · 2007 [cited by applicant]
US 20080152540A1 · Schorzman et al. · 2008 [cited by applicant]
US 20100063310A1 · Knepper et al. · 2010 [cited by applicant]
US 20100215959A1 · Jonschker et al. · 2010 [cited by applicant]
US 20120093746A1 · Moriya · 2012 [cited by applicant]
US 20130130508A1 · Wu et al. · 2013 [cited by applicant]
US 20180057732A1 · Babcock et al. · 2018 [cited by applicant]
US 20180362716A1 · Okamura · 2018 [cited by applicant]
US 20190112549A1 · Bauer et al. · 2019 [cited by applicant]
US 20200148831A1 · Okamura · 2020 [cited by applicant]
US 20200231608A1 · Okamura · 2020 [cited by applicant]
US 20210054002A1 · Asirvatham et al. · 2021 [cited by applicant]
US 20210186842A1 · Asirvatham · 2021 [cited by applicant]
US 20210187110A1 · Asirvatham · 2021 [cited by applicant]
US 20210187460A1 · Asirvatham · 2021 [cited by applicant]
US 20210188882A1 · Asirvatham · 2021 [cited by applicant]
US 20210189292A1 · Asirvatham · 2021 [cited by applicant]
US 20210198555A1 · Asirvatham · 2021 [cited by applicant]
US 20210230194A1 · Asirvatham et al. · 2021 [cited by applicant]
US 20210238479A1 · Asirvatham · 2021 [cited by applicant]
US 20220380669A1 · Asirvatham · 2022 [cited by applicant]
US 20230058204A1 · Asirvatham · 2023 [cited by applicant]
US 20240294556A1 · Asirvatham et al. · 2024 [cited by applicant]
US 20240376371A1 · Asirvatham · 2024 [cited by applicant]
CN 101356201A · 2009 [cited by applicant]
CN 102614808A · 2012 [cited by applicant]
CN 104826140A · 2015 [cited by applicant]
CN 107497365A · 2017 [cited by applicant]
CN 107522726A · 2017 [cited by applicant]
CN 107602862A · 2018 [cited by applicant]
CN 107698615A · 2018 [cited by applicant]
EP 0164514A1 · 1985 [cited by applicant]
EP 0436359A2 · 1991 [cited by applicant]
EP 2024423A2 · 2009 [cited by applicant]
EP 2458622A2 · 2012 [cited by applicant]
GB 1429143A · 1976 [cited by applicant]
GB 1470250A · 1977 [cited by applicant]
GB 1473201A · 1977 [cited by applicant]
GB 1473202A · 1977 [cited by applicant]
KR 1020120038898A · 2012 [cited by applicant]
KR 1020150108143A · 2015 [cited by applicant]
TW 201307372A · 2013 [cited by applicant]
TW 202112790A · 2021 [cited by applicant]
WO 0026206A1 · 2000 [cited by applicant]
WO 0246517A1 · 2002 [cited by applicant]
WO 0393352A1 · 2003 [cited by applicant]
WO 2007075320A2 · 2007 [cited by applicant]
WO 2007141565A2 · 2007 [cited by applicant]
WO 2009085297A2 · 2009 [cited by applicant]
WO 2015041214A1 · 2015 [cited by applicant]
WO 2016191148A1 · 2016 [cited by applicant]
WO 2021003455A1 · 2021 [cited by applicant]
WO 2021034550A1 · 2021 [cited by applicant]
Amino Acid—Britannica Online Encyclopedia (Jul. 17, 2009) (Year: 2009). [cited by applicant]
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2023/013612, mailed on Sep. 6, 2024, 08 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US20/64345, mailed on Apr. 12, 2021, 9 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US20/64347, mailed on Mar. 10, 2021, 7 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US20/64684, mailed on Mar. 25, 2021, 14 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US20/64687, mailed on Mar. 31, 2021, 12 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US20/64692, mailed on Apr. 7, 2021, 9 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US20/66027, mailed on Apr. 7, 2021, 12 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US20/66031, mailed on Apr. 8, 2021, 12 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2020/045797, mailed on Oct. 26, 2020, 11 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2023/013612, mailed on May 25, 2023, 10 pages. [cited by applicant]
Membership of the Commission, 56 Pure & Applied Chemistry, 595-624 (1984) (Year: 1984). [cited by applicant]
Stanbro et al., “Cationic silicones for use in contact lens application”, Polymer Preprints, 51(2), 2010, pp. 305-306. [cited by applicant]